Gian Pal is a Neurology physician affiliated with Rutgers. OpenAlex indexes 87 publications with 1,293 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Metro Blvd
Ste 3b
Clifton, NJ 07014
Telephone
732-321-7010Provider last certified this registry record 4 Feb 2026.
Clinical trials
- High Fiber in Parkinson's Disease
Sponsor: Rutgers, The State University of New Jersey
- Targeting Diet-Microbiome Interactions in the Pathogenesis of Parkinson's Disease
Sponsor: Rush University Medical Center
- Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Sponsor: Rutgers, The State University of New Jersey
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20254 payments
- Abbott LaboratoriesProgram year20251 payment
- Amneal Pharmaceuticals LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
91.3%Aromatic Amino Acid Decarboxylation Inhibitor42.6%Carbidopa-Levodopa59%Carbidopa-Levodopa Er27%Rytary14%Part D≥99 patientsBenzodiazepine11%Clonazepam100%Part D≥43 patients+ 10 more classes in this area
Cardiovascular
3%Beta blocker1.7%Propranolol Hcl Er100%Part D<11 patientsalpha-Adrenergic Agonist1.2%Midodrine Hcl100%Part D<11 patientsHormonal (systemic)
2.4%Mineralocorticoids2.4%Fludrocortisone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2021 per NIH RePORTER. The latest:
- Parkinson disease and DBS: cognitive effects in GBA mutation carriers
Rbhs-Robert Wood Johnson Medical School
FY2021$182,410K23NS097625 - Parkinson disease and DBS: cognitive effects in GBA mutation carriers
Rbhs-Robert Wood Johnson Medical School
FY2020$190,080K23NS097625
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effects of antimicrobial exposure on the risk of Parkinson's disease
Parkinsonism & Related Disorders
2024 - NIH Toolbox performance of persons with Parkinson's disease according to <i>GBA1</i> and STN‐DBS status
Annals of Clinical and Translational Neurology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Sherine Gabriel, MD
Rutgers
Julius Gardin, MD
Rutgers
Abraham Aviv, MD
Rutgers
Partho Sengupta, MD, DM
Rutgers
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”